Convenio Leucovorina y Diversos Fármacos
El objetivo de la presente licitación, es la adquisición de medicamentos, para el Hospital de Talca, con el fin de asegurar el abastecimiento en calidad y oportunidad, para satisfacer la demanda de los usuarios. El contrato es por 36 meses, a contar de la
7 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 5051-620-SE22 | 03-03-2022 | Deutsche Pharma S.A. | $317.016 |
| 5051-519-SE22 | 13-02-2022 | Deutsche Pharma S.A. | $1.057.006 |
| 5051-452-SE22 | 10-02-2022 | Laboratorios Saval S.A. | $309.400 |
| 5051-3751-SE21 | 31-12-2021 | Laboratorios Saval S.A. | $309.400 |
| 5051-3738-SE21 | 27-12-2021 | Deutsche Pharma S.A. | $528.503 |
| 5051-3076-SE21 | 27-10-2021 | Laboratorios Saval S.A. | $261.800 |
| 5051-2544-SE21 | 25-08-2021 | Laboratorios Andromaco S.A. | $161.186 |
| 5051-2275-SE21 | 08-07-2021 | Laboratorios Saval S.A. | $357.000 |
| 5051-2262-SE21 | 08-07-2021 | Laboratorios Andromaco S.A. | $161.186 |
| 5051-2061-SE21 | 12-06-2021 | Laboratorios Saval S.A. | $119.000 |
| 5051-1948-SE21 | 04-06-2021 | Laboratorios Andromaco S.A. | $161.186 |
| 5051-1670-SE21 | 05-05-2021 | Fresenius Kabi Chile Limitada | $2.975.000 |
| 5051-1547-SE21 | 29-04-2021 | Fresenius Kabi Chile Limitada | $2.380.000 |
| 5051-1408-SE21 | 13-04-2021 | Fresenius Kabi Chile Limitada | $2.380.000 |
| 5051-1295-SE21 | 13-04-2021 | Laboratorios Andromaco S.A. | $225.660 |
| 5051-1235-SE21 | 25-03-2021 | Fresenius Kabi Chile Limitada | $1.785.000 |
| 5051-958-SE21 | 03-03-2021 | Laboratorios Saval S.A. | $238.000 |
| 5051-929-SE21 | 02-03-2021 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 5051-741-SE21 | 22-02-2021 | Fresenius Kabi Chile Limitada | $1.785.000 |
| 5051-625-SE21 | 11-02-2021 | Novartis Chile S.A. | $3.016.650 |
| 5051-310-SE21 | 01-02-2021 | Novartis Chile S.A. | $2.506.140 |
| 5051-130-SE21 | 11-01-2021 | Laboratorios Saval S.A. | $247.520 |
| 5051-4463-SE20 | 14-12-2020 | Laboratorios Andromaco S.A. | $225.660 |
| 5051-3866-SE20 | 03-11-2020 | Laboratorios Andromaco S.A. | $193.423 |
| 5051-3371-SE20 | 14-09-2020 | Laboratorios Saval S.A. | $238.000 |
| 5051-3351-SE20 | 11-09-2020 | Laboratorios Andromaco S.A. | $193.423 |
| 5051-2923-SE20 | 14-08-2020 | Novartis Chile S.A. | $232.050 |
| 5051-2681-SE20 | 24-07-2020 | Laboratorios Andromaco S.A. | $64.474 |
| 5051-2679-SE20 | 24-07-2020 | Deutsche Pharma S.A. | $396.270 |
| 5051-2680-SE20 | 24-07-2020 | Laboratorios Saval S.A. | $38.080 |
| 5051-2220-SE20 | 13-07-2020 | Laboratorios Saval S.A. | $47.600 |
| 5051-2219-SE20 | 13-07-2020 | Deutsche Pharma S.A. | $607.614 |
| 5051-1824-SE20 | 18-05-2020 | Deutsche Pharma S.A. | $607.614 |
| 5051-1628-SE20 | 30-04-2020 | Laboratorios Saval S.A. | $249.900 |
| 5051-1064-SE20 | 18-03-2020 | Laboratorios Saval S.A. | $499.800 |
| 5051-1066-SE20 | 18-03-2020 | Laboratorios Andromaco S.A. | $644.742 |
| 5051-1063-SE20 | 18-03-2020 | Deutsche Pharma S.A. | $1.849.260 |
| 5051-678-SE20 | 12-02-2020 | Laboratorios Saval S.A. | $85.680 |
| 5051-265-SE20 | 27-01-2020 | Laboratorios Andromaco S.A. | $322.371 |
| 5051-263-SE20 | 17-01-2020 | Laboratorios Saval S.A. | $273.700 |
| 5051-136-SE20 | 13-01-2020 | Novartis Chile S.A. | $4.176.900 |
| 5051-5163-SE19 | 16-12-2019 | Deutsche Pharma S.A. | $1.849.260 |
| 5051-5165-SE19 | 16-12-2019 | Laboratorios Saval S.A. | $142.800 |
| 5051-5166-SE19 | 11-12-2019 | Laboratorios Andromaco S.A. | $161.186 |
| 5051-5008-SE19 | 05-12-2019 | Novartis Chile S.A. | $6.497.400 |
| 5051-4690-SE19 | 15-11-2019 | Deutsche Pharma S.A. | $1.849.260 |
| 5051-4692-SE19 | 15-11-2019 | Laboratorios Saval S.A. | $261.800 |
| 5051-4568-SE19 | 06-11-2019 | Novartis Chile S.A. | $6.497.400 |
| 5051-4280-SE19 | 18-10-2019 | Deutsche Pharma S.A. | $1.320.900 |
| 5051-4283-SE19 | 18-10-2019 | Laboratorios Andromaco S.A. | $322.371 |
| 5051-4282-SE19 | 18-10-2019 | Laboratorios Saval S.A. | $119.000 |
| 5051-4220-SE19 | 10-10-2019 | Novartis Chile S.A. | $1.392.300 |
| 5051-4100-SE19 | 09-10-2019 | Novartis Chile S.A. | $2.784.600 |
| 5051-3878-SE19 | 16-09-2019 | Laboratorios Andromaco S.A. | $214.200 |
| 5051-3879-SE19 | 16-09-2019 | Laboratorios Saval S.A. | $261.800 |
| 5051-3880-SE19 | 12-09-2019 | Laboratorios Andromaco S.A. | $322.371 |
| 5051-3662-SE19 | 03-09-2019 | Novartis Chile S.A. | $1.160.250 |
| 5051-3362-SE19 | 13-08-2019 | Laboratorios Andromaco S.A. | $161.186 |
| 5051-3359-SE19 | 09-08-2019 | Novartis Chile S.A. | $4.641.000 |
| 5051-3360-SE19 | 09-08-2019 | Laboratorios Andromaco S.A. | $214.200 |
| 5051-3361-SE19 | 09-08-2019 | Laboratorios Saval S.A. | $261.800 |
| 5051-2888-SE19 | 08-07-2019 | Laboratorios Andromaco S.A. | $214.200 |
| 5051-2886-SE19 | 08-07-2019 | Deutsche Pharma S.A. | $1.849.260 |
| 5051-2887-SE19 | 08-07-2019 | Novartis Chile S.A. | $3.248.700 |
| 5051-2890-SE19 | 08-07-2019 | Laboratorios Andromaco S.A. | $161.186 |
| 5051-2682-SE19 | 25-06-2019 | Novartis Chile S.A. | $3.248.700 |
| 5051-2459-SE19 | 11-06-2019 | Laboratorios Andromaco S.A. | $32.237 |
| 5051-2457-SE19 | 11-06-2019 | Laboratorios Andromaco S.A. | $214.200 |
| 5051-2458-SE19 | 11-06-2019 | Laboratorios Saval S.A. | $261.800 |
| 5051-2456-SE19 | 11-06-2019 | Deutsche Pharma S.A. | $1.849.260 |
| 5051-2268-SE19 | 31-05-2019 | Novartis Chile S.A. | $4.641.000 |
| 5051-1961-SE19 | 08-05-2019 | Deutsche Pharma S.A. | $1.902.096 |
| 5051-1765-SE19 | 25-04-2019 | Novartis Chile S.A. | $6.497.400 |
| 5051-1444-SE19 | 03-04-2019 | Laboratorios Andromaco S.A. | $257.897 |
| 5051-1443-SE19 | 03-04-2019 | Deutsche Pharma S.A. | $1.717.170 |
Fuente original:ficha mercadopublico.cl
